OLYMPUS CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,201 JPY | -1.19% |
|
-0.11% | +7.91% |
| Apr. 08 | Olympus to Return Land and Building to Shenzhen City Government | MT |
| Mar. 28 | Olympus Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024 | CI |
| Sales 2024 * | 929B 5.98B | Sales 2025 * | 988B 6.36B | Capitalization | 2,596B 16.72B |
|---|---|---|---|---|---|
| Net income 2024 * | 259B 1.67B | Net income 2025 * | 110B 711M | EV / Sales 2024 * | 2.71 x |
| Net cash position 2024 * | 78.83B 508M | Net cash position 2025 * | 127B 815M | EV / Sales 2025 * | 2.5 x |
| P/E ratio 2024 * |
10.4
x | P/E ratio 2025 * |
24.1
x | Employees | 32,844 |
| Yield 2024 * |
0.8% | Yield 2025 * |
0.89% | Free-Float | 88.47% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olympus Corporation
More recommendations
More press releases
More news
| 1 day | -1.14% | ||
| 1 week | -0.11% | ||
| Current month | -0.47% | ||
| 1 month | +1.92% | ||
| 3 months | -0.23% | ||
| 6 months | +14.99% | ||
| Current year | +7.91% |
1 week
2 083.00
2 241.50
1 month
2 050.002 293.00
Current year
1 935.502 304.00
1 year
1 782.002 482.50
3 years
1 782.003 198.00
5 years
1 159.003 198.00
10 years
752.503 198.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 56 | 17-03-31 |
Yasuo Takeuchi
CHM | Chairman | 67 | 80-03-31 |
John de Csepel
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sumitaka Fujita
BRD | Director/Board Member | 81 | 12-03-31 |
Gary Pruden
BRD | Director/Board Member | 61 | 22-05-31 |
Yasushi Shingai
BRD | Director/Board Member | 68 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.83% | 31 M€ | +10.71% | ||
| 2.11% | 11 M€ | +11.05% | - | |
| 1.55% | 251 M€ | +13.17% | ||
| 1.23% | 31,732 M€ | +14.37% | - | |
| 1.22% | 1,198 M€ | +13.45% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 2,202 | -1.17% | 417 000 |
| 24-04-24 | 2,228 | +2.46% | 2,774,700 |
| 24-04-23 | 2,174 | +0.14% | 2,493,400 |
| 24-04-22 | 2,171 | +3.55% | 4,617,300 |
| 24-04-19 | 2,096 | -5.16% | 10,478,800 |
Delayed Quote Japan Exchange, April 24, 2024 at 08:28 pm EDT
More quotes
Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows:
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Calendar
2024-05-09
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,228
JPY
Average target price
2,426
JPY
Spread / Average Target
+8.92%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.91% | 16.37B | |
| +8.78% | 219B | |
| +8.24% | 187B | |
| +11.16% | 134B | |
| +26.12% | 101B | |
| +0.30% | 62.27B | |
| +16.21% | 52.82B | |
| -1.63% | 47.49B | |
| -1.11% | 40.79B | |
| +12.16% | 39.35B |
- Stock Market
- Equities
- 7733 Stock
